Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
METTL14 divergent transcript (METTL14-DT) is a long non-coding RNA gene located adjacent to the METTL14 protein-coding gene[4]. Long non-coding RNAs such as METTL14-DT do not code for proteins but can regulate gene expression and chromatin structure. METTL14-DT is classified as a divergent transcript due to its orientation and position relative to METTL14. There is currently no evidence in the biomedical literature indicating that METTL14-DT itself serves as a therapeutic target (such as a receptor, enzyme, transporter, etc.), or that it is directly involved in any specific diseases or targeted by drugs. While METTL14, its protein neighbor, is well-studied as part of the m6A methyltransferase complex, METTL14-DT should not be confused with METTL14 or its protein product. Summary of findings: - METTL14-DT is distinct from METTL14 and is not itself a protein, methyltransferase, or therapeutic target. - METTL14-DT is best classified as a long non-coding RNA (lncRNA), specifically a divergent transcript[4]. - There is no evidence that METTL14-DT is druggable, targets any known pathways, or is involved in disease processes as of current data. If you were looking for information on METTL14 (the protein-coding methyltransferase), which is indeed a therapeutic target involved in RNA modification, refer to METTL14 (methyltransferase-like protein 14), not METTL14-DT.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on METTL14 divergent transcript (METTL14-DT).